Skip to content
10-Q

Quarterly Report

INNOVATION PHARMACEUTICALS INC.

0001477932-22-008313

← back to feed
Filed
Nov 10, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Nov 10, 2022 488.32M sh
Cash And Equivalents Q1 2023 · Sep 30, 2022 $2.97M
Cash And Equivalents Q1 2023 · Jun 30, 2022 $3.81M
Current Liabilities Q1 2023 · Sep 30, 2022 $5.13M
Current Liabilities Q1 2023 · Jun 30, 2022 $4.81M
Total Liabilities Q1 2023 · Sep 30, 2022 $5.92M
Total Liabilities Q1 2023 · Jun 30, 2022 $5.65M
Current Assets Q1 2023 · Sep 30, 2022 $3.09M
Current Assets Q1 2023 · Jun 30, 2022 $3.95M
Total Assets Q1 2023 · Sep 30, 2022 $9.34M
Total Assets Q1 2023 · Jun 30, 2022 $10.38M
Operating Cash Flow Q1 2023 · Sep 30, 2021 −$1.95M
Stockholders Equity Q1 2023 · Sep 30, 2021 $8.3M
Stockholders Equity Q1 2023 · Jun 30, 2021 $7.51M
Sga Expense Q1 2023 · Sep 30, 2021 $185K
Rd Expense Q1 2023 · Sep 30, 2021 $1.59M
Net Income Q1 2023 · Sep 30, 2021 −$2.06M
Operating Income Q1 2023 · Sep 30, 2021 −$2.02M
Revenue Q1 2023 · Sep 30, 2021 $0